OVD choices mean optimised outcomes

Article

Dr Stephen Lane believes that the large variety of available ophthalmic viscosurgical devices now allows the surgeon to tailor the surgery to meet any specific needs a patient may have.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Recent Videos
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
Concept image for the balancing of energy efficiency and time in refractive surgery phacoemulsification. A scale, with a laser beam of blue light on one side, and an analog alarm clock on the other side. The laser beam of blue light is surrounded by static. Created with Canva Magic AI.

Keys to optimising phaco efficiency

Marta Ibarz, MD, PhD
August 30th 2025
Article
Logos for Alcon, STAAR Surgical and the EVO ICL, on a turquoise background. Images courtesy of Alcon and STAAR Surgical.

Alcon announces acquisition of STAAR Surgical, EVO ICL lenses

Martin David Harp
August 30th 2025
Article
Frank Kerkhoff, MD, PhD, and visual acuity charts following implantation with the Johnson and Johnson Tecnis Odyssey lens.

Q&A: Early research findings and clinical experiences with a new multifocal IOL

Frank Kerkhoff, MD, PhD ;Hattie Hayes
August 30th 2025
Article
A row of beakers with yellow and orange fluid in a laboratory. Concept image for microbial lutein production, bioengineering, sustainable synthesis for cataract cornea age-related macular degeneration (AMD) and retinal disease. Image credit: bidala – stock.adobe.com

New microbial strain produces high yields of lutein for AMD, cataract prevention

Kassi Filkins
August 30th 2025
Article
Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients

Jordana Joy
August 30th 2025
Article
A Canadian flag in front of a mountain range. Concept image for Alcon Clareon Panoptix Pro intraocular lens IOL launch and approval in Canada. Image credit: ©toptop54 from pixabay - Canva.com

Clareon Panoptix Pro IOL (Alcon) approved in Canada

Jordana Joy
August 30th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.